ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

ADVFN

Trade Now

EasyMarkets
Market Data
News
Tools
Markets
Discover
Subscribe Login/Register Profile Icon
S&P 500
4,594.63
(
0.59%
)
US Tech 100
15,629.20
(
0.49%
)
Dow Jones
36,245.50
(
0.82%
)
Brent Oil
78.165
(
-1.82%
)
Bitcoin
41,666.49
(
4.21%
)
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Amgen Inc (AMGN)

  7. Amgen Inc (AMGN) News

AMGN Amgen Inc

272.45
2.81 (1.04%)
Dec 01 2023 - Closed
Delayed by 15 minutes
Company Name Stock Ticker Symbol Market Type
Amgen Inc AMGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
Upgrade Icon
2.81 1.04% 272.45 19:49:08
Open Price Low Price High Price Close Price Prev Close
269.65 267.62 272.59 272.45 269.64
more quote information »

Recent News

Date Time Source Heading
11/29/202320:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/22/202316:00PRNUSAMGEN TO PRESENT AT THE EVERCORE ISI HEALTHCONX CONFERENCE
11/13/202320:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/10/202309:00PRNUSAMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
11/08/202314:11EDGAR2Form 144 - Report of proposed sale of securities
11/07/202320:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202320:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202320:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202320:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202320:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202320:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202320:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/07/202316:05PRNUSAMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT..
11/07/202316:00PRNUSAMGEN PRESENTS NEW DATA FROM PHASE 2 TRIAL OF DAZODALIBEP IN..
11/06/202311:00PRNUSEpidemiology and Genetics of Clonal Hematopoiesis, a..
11/03/202319:44EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/03/202319:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/02/202308:00PRNUSAMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES..
11/01/202309:00PRNUSAMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED..
11/01/202308:45IHNWGet Ready for Next Generation of Diabetes, Weight-Management..
10/31/202319:35DJNAmgen Gets FDA Approval for Inflammatory Diseases Treatment
10/31/202316:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/202310:43DJNAmgen on Pace for Largest Percent Decrease Since September..
10/31/202310:36DJNTrending: Amgen's Quarterly Profits Top Street Views
10/31/202307:38DJNAmgen Lifts FY23 Guidance After 3Q Adjusted Profit Tops..
10/31/202307:30DJNAmgen 3Q Profit Sinks On Discontinued Development Charge
10/31/202307:24IHMARKETNEWSTuesday’s Wall Street Highlights: Pinterest, BP, Wolfspeed,..
10/31/202307:15EDGAR2Form 8-K - Current report
10/31/202307:00PRNUSAMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
10/25/202316:00PRNUSAMGEN ANNOUNCES WEBCAST OF 2023 THIRD QUARTER FINANCIAL..
10/24/202316:00PRNUSAMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND
10/24/202313:20DJNAmgen to Lay Off 350 U.S. Employees of Horizon Therapeutics
10/22/202310:30PRNUSAMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX®..
10/20/202308:00PRNUSAMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
10/19/202316:00PRNUSAMGEN TO WEBCAST INVESTOR CALL AT ESMO 2023
10/19/202306:06IHMARKETNEWSKeep An Eye Out: Pre-Market Movers And Analyst..
10/16/202309:00PRNUSAMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND..
10/11/202314:49DJNAmgen Best Performer in the DJIA, S&P 500 and Nasdaq 100 So..
10/09/202307:33IHMARKETNEWSMonday’s Wall Street Highlights: Exxon Mobil, Bristol-Myers,..
10/06/202316:35EDGAR2Form S-8 - Securities to be offered to employees in employee..
10/06/202316:01EDGAR2Form 8-K - Current report
10/06/202308:30PRNUSAMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
10/05/202307:43EDGAR2Form 8-K - Current report
10/04/202311:00PRNUSLarge-scale proteomics in population-based studies from UK..
9/27/202307:30EDGAR2Form SC 13D - General statement of acquisition of beneficial..
9/20/202316:00PRNUSAMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING..
9/19/202319:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/14/202318:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
9/12/202307:30EDGAR2Form 8-K - Current report
9/11/202316:00PRNUSAMGEN TO PRESENT AT THE BANK OF AMERICA MERRILL LYNCH GLOBAL..

Your Recent History

NASDAQ
AMGN
Amgen
Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com